KARABELAS ARGERIS N
Insider CIK 1191229 · ITEK Director, 10% owner · RGNX Director · VRX Director · HGSI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RGNX REGENXBIO Inc. | A Award deriv | 2026-05-29 | 2026-06-02 | 46,600 | — | $0 | 46,600 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award | 2026-05-29 | 2026-06-02 | 9,807 | — | $0 | 28,861 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2025-05-30 | 2025-06-03 | 39,815 | — | $0 | 39,815 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award | 2025-05-30 | 2025-06-03 | 7,768 | — | $0 | 19,054 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2024-10-01 | 2024-10-02 | 10,000 | — | $0 | 0 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2024-10-01 | 2024-10-02 | 10,000 | $10.11 | $101.1K | 11,286 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2024-10-01 | 2024-10-02 | 10,000 | $3.76 | $37.6K | 21,286 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2024-09-03 | 2024-09-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2024-09-03 | 2024-09-04 | 9,300 | $11.50 | $107.0K | 11,986 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2024-09-03 | 2024-09-04 | 700 | $12.34 | $8.6K | 11,286 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2024-09-03 | 2024-09-04 | 10,000 | $3.76 | $37.6K | 21,286 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2024-08-01 | 2024-08-05 | 100 | — | $0 | 1,400 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2024-08-01 | 2024-08-05 | 10,000 | — | $0 | 20,000 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2024-08-01 | 2024-08-05 | 100 | $15.00 | $1.5K | 11,286 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2024-08-01 | 2024-08-05 | 10,000 | $3.76 | $37.6K | 21,286 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2024-08-01 | 2024-08-05 | 100 | $12.74 | $1.3K | 21,386 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2024-08-01 | 2024-08-05 | 9,600 | $13.45 | $129.1K | 11,786 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2024-08-01 | 2024-08-05 | 400 | $14.59 | $5.8K | 11,386 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2024-07-29 | 2024-07-30 | 11,000 | — | $0 | 1,500 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2024-07-29 | 2024-07-30 | 11,000 | $12.74 | $140.1K | 22,286 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2024-07-29 | 2024-07-30 | 11,000 | $15.05 | $165.6K | 11,286 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise deriv | 2024-07-01 | 2024-07-03 | 10,000 | — | $0 | 30,000 | SEC↗ |
| RGNX REGENXBIO Inc. | M Exercise | 2024-07-01 | 2024-07-03 | 10,000 | $3.76 | $37.6K | 21,286 | SEC↗ |
| RGNX REGENXBIO Inc. | S Sale | 2024-07-01 | 2024-07-03 | 10,000 | $11.27 | $112.7K | 11,286 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2024-05-31 | 2024-06-04 | 24,454 | — | $0 | 24,454 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award | 2024-05-31 | 2024-06-04 | 4,790 | — | $0 | 11,286 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2023-06-02 | 2023-06-06 | 17,892 | — | $0 | 17,892 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award | 2023-06-02 | 2023-06-06 | 3,486 | — | $0 | 6,496 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2022-06-24 | 2022-06-28 | 34,387 | — | $0 | 123,715 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2022-06-03 | 2022-06-07 | 15,324 | — | $0 | 15,324 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award | 2022-06-03 | 2022-06-07 | 3,010 | — | $0 | 3,010 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2021-06-04 | 2021-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2021-04-30 | 2021-05-03 | 7,645 | — | $0 | 89,328 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2020-05-29 | 2020-06-02 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2020-05-01 | 2020-05-01 | 11,037 | — | $0 | 81,683 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2019-05-31 | 2019-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2019-05-03 | 2019-05-03 | 10,633 | $23.51 | $250.0K | 70,646 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2018-05-25 | 2018-05-30 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2018-05-03 | 2018-05-04 | 14,285 | — | $0 | 60,417 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2018-05-03 | 2018-05-08 | 13,881 | — | $0 | 60,013 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2017-05-24 | 2017-05-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2017-05-05 | 2017-05-05 | 25,406 | — | $0 | 46,132 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2016-08-11 | 2016-08-12 | 4,000 | $24.65 | $98.6K | 20,726 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2016-06-17 | 2016-06-21 | 16,726 | — | $0 | 16,726 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2016-06-01 | 2016-06-02 | 12,500 | — | $0 | 12,500 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2015-09-16 | 2015-09-17 | 5,208 | — | $0 | 5,208 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2015-09-16 | 2015-09-22 | 9,375 | — | $0 | 9,375 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | A Award deriv | 2015-06-24 | 2015-06-26 | 12,000 | $5.03 | $60.4K | 21,857 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | C Conversion deriv | 2015-02-23 | 2015-02-25 | 0 | — | $0 | 0 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | C Conversion deriv | 2015-02-23 | 2015-02-25 | 4,459,658 | — | $0 | 0 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | C Conversion | 2015-02-23 | 2015-02-25 | 1,394,645 | — | $0 | 1,609,747 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | P Buy | 2015-02-23 | 2015-02-25 | 603,832 | $6.00 | $3.62M | 2,277,139 | SEC↗ |
| ITEK INOTEK PHARMACEUTICALS COR | C Conversion | 2015-02-23 | 2015-02-25 | 63,560 | — | $0 | 1,673,307 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer deriv | 2012-07-30 | 2012-08-01 | 16,000 | $14.25 | $228.0K | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer deriv | 2012-07-30 | 2012-08-01 | 16,000 | $14.25 | $228.0K | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer deriv | 2012-07-30 | 2012-08-01 | 48,000 | $14.25 | $684.0K | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer deriv | 2012-07-30 | 2012-08-01 | 16,000 | $14.25 | $228.0K | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer deriv | 2012-07-30 | 2012-08-01 | 16,000 | $14.25 | $228.0K | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer deriv | 2012-07-30 | 2012-08-01 | 16,000 | $14.25 | $228.0K | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer deriv | 2012-07-30 | 2012-08-01 | 16,000 | $14.25 | $228.0K | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | U Tender | 2012-07-30 | 2012-08-01 | 17,776 | $14.25 | $253.3K | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer | 2012-07-30 | 2012-08-01 | 4,166 | $14.25 | $59.4K | 17,776 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | A Award | 2012-07-10 | 2012-07-11 | 728 | $13.64 | $9.9K | 21,942 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | A Award deriv | 2012-05-17 | 2012-05-21 | 16,000 | — | $0 | 16,000 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | A Award | 2012-05-17 | 2012-05-21 | 2,500 | — | $0 | 21,214 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | A Award | 2012-04-10 | 2012-04-12 | 1,120 | $7.53 | $8.4K | 18,714 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | A Award | 2012-01-10 | 2012-01-11 | 1,237 | $8.03 | $9.9K | 17,594 | SEC↗ |